ExtreMed
Extreme Ultrashort Pulses for Advanced Medical Applications and Diagnostics
Over the past several years, in vivo imaging of brain and tumours using multiphoton microscopy has emerged as a powerful research as well as pre-clinical tool for revealing detailed cellular and functional behaviours. Multiphoton microscopy allows for deep tissue penetration with relatively minor phototoxicity, rendering it an effective tool for the long-term observations of live tissue.
ExtreMed is a partnership between Sphere Photonics, INL, UPorto and two faculty members UT Austin (Adela Ben-Yakar and Andrew Dunn). This partnership will focus on the development and application of ultrashort laser pulses for biomedical imaging
and diagnostics, with a goal to eventually guide therapeutics by bringing together an innovative laser company together with two Portuguese institutions and two UT Austin faculty who are established leaders in the field of biomedical optics and imaging.
The research performed at UT Austin, INL and UPorto will use technology developed by Sphere Ultrafast Photonics and the other partners to push the speed and imaging depth of several new imaging techniques to new limits.
Total Eligible Budget
1,281,911.16 €
INL Eligible Budget
498,978.25 €
Total Funding
945,843.69 €
INL Funding
498,978.25 €
Start Date
01-04-2020
End Date
30-06-2023
Type of action
SI – Projetos em Copromoção
Grant Agreement Id
NORTE-01-0247-FEDER-045932
Funding Agency
CCDR-N / FCT
Programme
POCI – PROGRAMA OPERACIONAL COMPETITIVIDADE E INTERNACIONALIZAÇÃO
Funding Framework
PORTUGAL 2020
INL Role
Partner
Approval Date
09-12-2019
Intervention Region
North of Portugal
Main Objective